Genomic Precision

 A SeraCare blog focused on precision medicine and advanced clinical diagnostics

Reliable Interpretation of NGS Data: New Poster Talk Video

Posted by Cynthia Hendrickson, CEO Directed Genomics on Feb 1, 2018 8:00:00 AM

The ability to rapidly and effectively evaluate the performance of customized next-generation sequencing (NGS) panels is critical to provide high-quality sequencing solutions to customers. New England Biolabs®, together with Directed Genomics®, is developing a new offering, NEBNext Direct® Custom Ready Panels, which will allow researchers to select from a large library of genes for which baits have been developed and optimized, thus enabling rapid deployment of customized target-enrichment panels. Directed Genomics has been collaborating with SeraCare Life Sciences in order to streamline the optimization and characterization of NEBNext Direct target enrichment panels. 

Read More

Topics: reference materials, NGS reference materials, NGS, SeraSeq, NGS assays, Variant Allele Frequencies, highly-multiplexed reference material, AMP2017

Does your NGS lab struggle with quality control? [Free Guide]

Posted by Meagan Gregoire on Aug 11, 2017 12:02:00 PM

As clinical genomics diagnostics continues to evolve, the primary challenge for laboratories has shifted from data acquisition, to ensuring their NGS tests are safe and effective. Whether they are developing an assay for circulating tumor DNA, validating a test to predict an antiviral therapy response, or are in production to provide parents with life changing health information, the underlining goal remains the same: your results must be accurate, precise, and consistent. High-quality, highly-multiplexed reference materials and the effective use of quality control metrics for monitoring the health of your assays are two solutions to help achieve those goals.

Read More

Topics: QC Challenges, NGS-Based Tests, highly-multiplexed reference material, clinical genomics

 
 

Subscribe for Updates

Recent Posts

Categories

see all